tenk.fyi

4D Molecular Therapeutics, Inc.

FDMTNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$85.2M

230194.6% YoY

Net Income

-$140.1M

12.9% YoY

EPS

$-2.42

18.8% YoY

Cash

$60.2M

59.7% YoY

FY 2025 · As of 2025-12-31

No recent insider transactions found.

ProShowing last 90 days. Full 12+ month history available on Pro.
Upgrade